S-adenosylmethionine (SAMe) is an important methyl donor and antioxidant. Depressed SAMe levels are observed in multiple forms of experimental liver injury, and SAMe therapy is an effective hepatoprotective agent in diverse forms of experimental liver injury. SAMe is available as a complementary and alternative medicine and is widely used to treat several forms of liver disease as well as depression. Likely therapeutic properties of SAMe include its effects on methylation, antioxidant status, mitochondrial function, hepatocyte differentiation, cytokine metabolism, and/or antidepressive functions. In this proposal, we will evaluate potential benefits of SAMe in an emerging major health problem in the U.S., non-alcoholic steatohepatitis (NASH). While the etiology of NASH still remains unclear, most investigators agree that a baseline of steatosis requires a second """"""""hit"""""""" capable of inducing inflammation, fibrosis or necrosis in order to develop NASH. The focus of our research group has been the interactions of cytokines, oxidative stress with lipid peroxidation, and mitochondrial dysfunction in the induction of steatohepatitis, both alcoholic and nonalcoholic in origin. Recent research from other laboratories also supports increased cytokine activity, oxidative stress, and mitochondrial dysfunction in the pathogenesis of NASH. Our long-term goal is to further understand mechanism(s) of action of SAMe in liver disease. In this proposal we will evaluate specific mechanisms of action of SAMe in the human liver disease NASH. This is not a clinical trial, but a mechanistic translational study. The specific objectives for this proposal are: 1 .Evaluate mechanisms for dysregulated TNF/cytokine production in patients with NASH and determine whether or not SAMe in vitro/ex vivo favorably modulates this abnormal cytokine metabolism; 2. Evaluate in vivo mechanisms of action of SAMe in NASH patients, including antioxidant status, cytokine metabolism, liver function, and quality of life issues; 3. Determine whether or not hepatic methyltransferases are decreased in NASH and improve with SAMe therapy; and 4. Determine by proteomic analysis of serum and liver biopsies the proteins (esp. oxidative stress, oxidized and mitochondrial proteins) that may play a role in the diagnosis or etiology of NASH, and which may be modified by SAMe therapy ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK071765-01
Application #
6956821
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Doo, Edward
Project Start
2005-09-15
Project End
2010-07-31
Budget Start
2005-09-15
Budget End
2006-07-31
Support Year
1
Fiscal Year
2005
Total Cost
$308,700
Indirect Cost
Name
University of Louisville
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Song, Ming; Chen, Theresa; Prough, Russell A et al. (2016) Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response. Alcohol Clin Exp Res 40:518-28
Wei, Xiaoli; Song, Ming; Yin, Xinmin et al. (2015) Effects of Dietary Different Doses of Copper and High Fructose Feeding on Rat Fecal Metabolome. J Proteome Res 14:4050-8
Song, Ming; Schuschke, Dale A; Zhou, Zhanxiang et al. (2015) Kupffer cell depletion protects against the steatosis, but not the liver damage, induced by marginal-copper, high-fructose diet in male rats. Am J Physiol Gastrointest Liver Physiol 308:G934-45
Shi, Xue; Wei, Xiaoli; Koo, Imhoi et al. (2014) Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced Fatty liver disease. J Proteome Res 13:547-554
Watson, Walter H; Burke, Tom J; Doll, Mark A et al. (2014) S-adenosylhomocysteine inhibits NF-?B-mediated gene expression in hepatocytes and confers sensitivity to TNF cytotoxicity. Alcohol Clin Exp Res 38:889-96
Kirpich, Irina; Zhang, Jingwen; Gobejishvili, Leila et al. (2013) Binge ethanol-induced HDAC3 down-regulates Cpt1? expression leading to hepatic steatosis and injury. Alcohol Clin Exp Res 37:1920-9
Kirpich, Irina A; Feng, Wenke; Wang, Yuhua et al. (2013) Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol. Alcohol 47:257-64
Song, Ming; Schuschke, Dale A; Zhou, Zhanxiang et al. (2013) Modest fructose beverage intake causes liver injury and fat accumulation in marginal copper deficient rats. Obesity (Silver Spring) 21:1669-75
Bull-Otterson, Lara; Feng, Wenke; Kirpich, Irina et al. (2013) Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One 8:e53028
Kirpich, Irina; Ghare, Smita; Zhang, Jingwen et al. (2012) Binge alcohol-induced microvesicular liver steatosis and injury are associated with down-regulation of hepatic Hdac 1, 7, 9, 10, 11 and up-regulation of Hdac 3. Alcohol Clin Exp Res 36:1578-86

Showing the most recent 10 out of 31 publications